Biochemical markers in human breast cancer
- PMID: 64663
- DOI: 10.1016/s0140-6736(77)91719-6
Biochemical markers in human breast cancer
Abstract
Nineteen biochemical parameters, most of which have been individually advocated as tumour-index-substances for breast cancer, were measured in 51 patients with breast disease, 42 of whom had active breast cancer. Seven of these parameters were raised in more than half of the 17 patients of the series with overt metastases; these were serum ferritin (88%), C-reactive protein (87%), carcinoembryonic antigen (81%), acid glycoprotein (75%), total alkaline phosphatase (64%), sialyl transferase (56%), andthe urinary hydroxyproline/creatinine ratio (73%). The incidence of biochemical abnormalities in patients in this group compared favourably with the results of physical methods of detecting metastases. 7 of 16 further patients without evidence of distant metastases, but who had a poor prognosis as judged by histology of the primary tumour and axillary lymph-nodes, had abnormalities of at least one of the seven parameters. 3 of these patients have relapsed within a year of mastectomy. The results suggest that these biochemical tests could assist in monitoring metastatic disease and could indicate at the time of mastectomy, patients who might benefit from immediate systemic therapy in addition to local treatment of their breast carcinomas.
Similar articles
-
A biochemical approach to the staging of human breast cancer.Cancer. 1977 Aug;40(2):937-44. doi: 10.1002/1097-0142(197708)40:2<937::aid-cncr2820400252>3.0.co;2-d. Cancer. 1977. PMID: 890676 No abstract available.
-
Assessment of biochemical tests to screen for metastases in patients with breast cancer.Lancet. 1980 Feb 9;1(8163):296-7. doi: 10.1016/s0140-6736(80)90790-4. Lancet. 1980. PMID: 6101748 Clinical Trial.
-
Screening for metastases in breast cancer: an assessment of biochemical and physical methods.Cancer. 1981 Jul 15;48(2):310-5. doi: 10.1002/1097-0142(19810715)48:2<310::aid-cncr2820480216>3.0.co;2-v. Cancer. 1981. PMID: 6113047
-
Markers in breast and lung cancer.Ann Clin Biochem. 1982 Jul;19 (Pt 4):263-8. doi: 10.1177/000456328201900415. Ann Clin Biochem. 1982. PMID: 6127052 Review.
-
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.Dan Med J. 2012 Jul;59(7):B4475. Dan Med J. 2012. PMID: 22759850 Review.
Cited by
-
Tumour markers in breast cancer.Br J Cancer. 1979 Nov;40(5):710-8. doi: 10.1038/bjc.1979.251. Br J Cancer. 1979. PMID: 92331 Free PMC article.
-
Monocyte maturation and prognosis in primary breast cancer.Br Med J. 1979 Apr 21;1(6170):1050-1. doi: 10.1136/bmj.1.6170.1050-a. Br Med J. 1979. PMID: 444917 Free PMC article. No abstract available.
-
A traction force threshold signifies metastatic phenotypic change in multicellular epithelia.Soft Matter. 2019 Sep 18;15(36):7203-7210. doi: 10.1039/c9sm00733d. Soft Matter. 2019. PMID: 31475279 Free PMC article.
-
Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.Br J Cancer. 1980 May;41(5):745-50. doi: 10.1038/bjc.1980.136. Br J Cancer. 1980. PMID: 6158966 Free PMC article.
-
Tests for detecting recurrent disease in the follow-up of patients with breast cancer.Breast Cancer Res Treat. 1988 Jul;11(3):249-54. doi: 10.1007/BF01807283. Breast Cancer Res Treat. 1988. PMID: 3167230
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials